欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
EE/H/0189/002
药品名称
Cilozek
活性成分
cilostazol 100.0 mg
剂型
Tablet
上市许可持有人
Adamed Pharma S.A. Pieńków, ul. M. Adamkiewicza 6A 05-152 Czosnów Poola
参考成员国 - 产品名称
Estonia (EE)
CILOZEK
互认成员国 - 产品名称
Spain (ES)
Greece (GR)
CILOSTAZOL/ADAMED
Poland (PL)
Cilozek
Hungary (HU)
CILOZEK 100 mg tabletta
Romania (RO)
Cilozek 100 mg comprimate
许可日期
2014/02/09
最近更新日期
2023/11/24
药物ATC编码
B01AC23 cilostazol
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
LAB-EE_189_002_clean
Date of last change:2019/04/29
Final PL
|
PIL-EE_189_002_clean
Date of last change:2019/04/29
Final SPC
|
SPC-EE_189_002_clean
Date of last change:2019/04/29
PAR
|
PublicAR-cilozek
Date of last change:2014/05/05
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase